Product InformationRegistration Status: Active
LASTACAFT (ALCAFTADINE OPHTHALMIC SOLUTION) 0.25% is approved to be sold in Singapore with effective from 2013-01-24. It is marketed by ALLERGAN SINGAPORE PTE LTD, with the registration number of SIN14297P.
This product contains Alcaftadine 2.5mg/mL in the form of SOLUTION, STERILE. It is approved for OPHTHALMIC use.
This product is manufactured by JHP Pharmaceuticals in UNITED STATES.
It is a has been granted the exemption for supply without a presciption if it met certain criteria.
Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010.
For the prevention of itching associated with allergic conjunctivitis.
Mechanism of Action
Alcaftadine is a H1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated.
6,11-Dihydro-11-(1-Methyl-4-piperidinylidene)-5H-iMidazo[2,1-b]benzazepine-3-carboxaldehyde | Alcaftadina | Alcaftadinum | Vilasta | Alcaftadine |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.